Farzaneh Raoufi
Nurse Practitioner · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Farzaneh Raoufi’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$0 in 2023
Medicaid paid $0 for 1,666 billed services this clinician did in 2023, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ELECTROLYTE PANEL | 150 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 109 | $0 |
| HEPATIC FUNCTION PANEL | 126 | $0 |
| Creatinine; blood | 150 | $0 |
| Measurement of ferritin | 13 | $0 |
| Blood glucose (sugar) level | 152 | $0 |
| Hemoglobin A1C level | 188 | $0 |
| Measurement of iron | 13 | $0 |
| IRON BINDING CAPACITY | 13 | $0 |
| Thyroid stimulating hormone (TSH) | 137 | $0 |
| Urea nitrogen; quantitative | 150 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 157 | $0 |
| 2023 | 1,666 | 21 | 35 | $0 |
| 2022 | 1,770 | 20 | 45 | $19,450 |
| 2021 | 4,055 | 26 | 93 | $376,550 |
| 2020 | 1,110 | 17 | 75 | $144,547 |
| 2019 | 47 | 2 | 16 | $11,621 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 41 | $19,450 |
| ELECTROLYTE PANEL | 152 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 97 | $0 |
| HEPATIC FUNCTION PANEL | 149 | $0 |
| Creatinine; blood | 152 | $0 |
| Blood glucose (sugar) level | 155 | $0 |
| Hemoglobin A1C level | 177 | $0 |
| Thyroid stimulating hormone (TSH) | 168 | $0 |
| Urea nitrogen; quantitative | 152 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 162 | $0 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 65 | $0 |
| Assay for total hepatitis B core antibody (HBcAb) | 14 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 806 | $376,550 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 102 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 185 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 182 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| ELECTROLYTE PANEL | 122 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 63 | $0 |
| HEPATIC FUNCTION PANEL | 152 | $0 |
| Creatinine; blood | 122 | $0 |
| Measurement of ferritin | 12 | $0 |
| Blood glucose (sugar) level | 127 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 434 | $144,473 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 17 | $74 |
| ELECTROLYTE PANEL | 13 | $0 |
| HEPATIC FUNCTION PANEL | 15 | $0 |
| Creatinine; blood | 13 | $0 |
| Blood glucose (sugar) level | 13 | $0 |
| Hemoglobin A1C level | 17 | $0 |
| Thyroid stimulating hormone (TSH) | 14 | $0 |
| Urea nitrogen; quantitative | 13 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 17 | $0 |
| HEPATITIS C ANTIBODY | 12 | $0 |
| IMMUNOLOGY PROCEDURE | 12 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 33 | $11,621 |
| Short return visit (20+ min) | 14 | $0 |
Drugs they prescribed that Part D paid
$236,499
Pharmacies billed $236,499 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 1,669) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,417 generic and fewer than 11 brand-name prescriptions · $236,499 in drug cost · 26 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 50 | $70,740 | $1,415 |
| Rybelsus | 28 | $38,143 | $1,362 |
| Eliquis | 17 | $23,544 | $1,385 |
| Trulicity | 17 | $23,332 | $1,372 |
| Ozempic | 15 | $20,404 | $1,360 |
See all 42 drugs
| Jardiance | 50 | $70,740 | $1,415 |
| Rybelsus | 28 | $38,143 | $1,362 |
| Eliquis | 17 | $23,544 | $1,385 |
| Trulicity | 17 | $23,332 | $1,372 |
| Ozempic | 15 | $20,404 | $1,360 |
| Tradjenta | 13 | $16,444 | $1,265 |
| Atorvastatin | 188 | $1,060 | $6 |
| Albuterol Sulfate Hfa | 25 | $906 | $36 |
| Losartan | 85 | $563 | $7 |
| Fosinopril | 23 | $554 | $24 |
| Metformin | 68 | $413 | $6 |
| Fluticasone Propionate | 41 | $410 | $10 |
| Diclofenac | 23 | $372 | $16 |
| Levothyroxine | 34 | $311 | $9 |
| Pantoprazole | 16 | $297 | $19 |
| Baclofen | 22 | $294 | $13 |
| Lisinopril | 56 | $290 | $5 |
| Mirtazapine | 19 | $290 | $15 |
| Amlodipine Besylate | 99 | $289 | $3 |
| Gabapentin | 31 | $280 | $9 |
| Famotidine | 31 | $251 | $8 |
| Clotrimazole | 13 | $250 | $19 |
| Hydralazine | 17 | $246 | $14 |
| Tamsulosin | 19 | $239 | $13 |
| Omeprazole | 36 | $230 | $6 |
| Glipizide | 24 | $209 | $9 |
| Ezetimibe | 12 | $182 | $15 |
| Alendronate | 39 | $178 | $5 |
| Furosemide | 25 | $158 | $6 |
| Metoprolol | 13 | $150 | $12 |
| Hydrocortisone | 27 | $125 | $5 |
| Montelukast | 13 | $117 | $9 |
| Metformin Hcl Er | 12 | $113 | $9 |
| Triamcinolone Acetonide | 22 | $91 | $4 |
| Pramipexole Dihydrochloride | 11 | $78 | $7 |
| Metoprolol | 19 | $73 | $4 |
| Chlorhexidine Gluconate | 14 | $63 | $4 |
| Naproxen | 18 | $54 | $3 |
| Hydroxyzine | 15 | $52 | $3 |
| Simvastatin | 12 | $52 | $4 |
| Hydrochlorothiazide | 17 | $32 | $2 |
| Ondansetron | 11 | $27 | $2 |
Year by year
| 2024 | 1,669 | 159 | 1% (15) | None | $236,499 |
| 2023 | 1,439 | 156 | 1% (16) | None | $270,902 |
| 2022 | 939 | 137 | 1% (11) | None | $121,324 |
| 2021 | 878 | 127 | None | None | $78,107 |
| 2020 | 1,246 | 184 | 1% (13) | None | $88,655 |
| 2019 | 1,549 | 229 | 2% (23) | None | $77,285 |
| 2018 | 1,190 | 223 | None | None | $52,274 |
| 2017 | 719 | 182 | 3% (19) | None | $34,506 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 42 drugs
| Jardiance | 57 | $70,941 | $1,245 |
| Rybelsus | 28 | $35,446 | $1,266 |
| Tradjenta | 20 | $25,229 | $1,261 |
| Eliquis | 21 | $23,611 | $1,124 |
| Trulicity | 18 | $22,016 | $1,223 |
| Ozempic | 13 | $12,618 | $971 |
| Advair Diskus | 16 | $6,955 | $435 |
| Flovent Hfa | 11 | $3,216 | $292 |
| Atorvastatin | 128 | $3,136 | $24 |
| Amlodipine Besylate | 65 | $1,318 | $20 |
| Losartan | 58 | $1,312 | $23 |
| Albuterol Sulfate Hfa | 25 | $1,054 | $42 |
| Metformin | 63 | $893 | $14 |
| Famotidine | 29 | $875 | $30 |
| Diclofenac | 32 | $746 | $23 |
| Fluticasone Propionate | 34 | $723 | $21 |
| Levothyroxine | 45 | $719 | $16 |
| Tamsulosin | 14 | $694 | $50 |
| Pantoprazole | 16 | $567 | $35 |
| Mirtazapine | 22 | $561 | $25 |
| Ezetimibe | 16 | $559 | $35 |
| Alendronate | 31 | $505 | $16 |
| Montelukast | 16 | $476 | $30 |
| Lisinopril | 22 | $450 | $20 |
| Pravastatin | 11 | $393 | $36 |
| Ammonium Lactate | 13 | $369 | $28 |
| Glipizide | 26 | $365 | $14 |
| Baclofen | 22 | $359 | $16 |
| Omeprazole | 14 | $286 | $20 |
| Gabapentin | 26 | $269 | $10 |
| Furosemide | 25 | $253 | $10 |
| Metformin Hcl Er | 11 | $230 | $21 |
| Pioglitazone | 11 | $180 | $16 |
| Hydralazine | 13 | $145 | $11 |
| Triamcinolone Acetonide | 14 | $142 | $10 |
| Hydrocodone-Acetaminophen | 11 | $126 | $11 |
| Acyclovir | 13 | $121 | $9 |
| Metoprolol | 12 | $99 | $8 |
| Naproxen | 16 | $89 | $6 |
| Hydroxyzine | 13 | $88 | $7 |
| Hydrocortisone | 13 | $73 | $6 |
| Simvastatin | 11 | $57 | $5 |
2022: 25 drugs
| Jardiance | 16 | $21,828 | $1,364 |
| Rybelsus | 15 | $14,667 | $978 |
| Trulicity | 15 | $13,017 | $868 |
| Tradjenta | 12 | $9,552 | $796 |
| Atorvastatin | 82 | $1,401 | $17 |
| Ezetimibe | 13 | $1,097 | $84 |
| Albuterol Sulfate Hfa | 18 | $794 | $44 |
| Losartan | 33 | $598 | $18 |
| Levothyroxine | 21 | $545 | $26 |
| Baclofen | 18 | $526 | $29 |
| Metformin | 49 | $500 | $10 |
| Lisinopril | 29 | $400 | $14 |
| Fosinopril | 15 | $399 | $27 |
| Amlodipine Besylate | 49 | $389 | $8 |
| Omeprazole | 27 | $379 | $14 |
| Pantoprazole | 13 | $350 | $27 |
| Rosuvastatin | 16 | $339 | $21 |
| Fluticasone Propionate | 30 | $308 | $10 |
| Furosemide | 28 | $235 | $8 |
| Famotidine | 16 | $226 | $14 |
| Alendronate | 13 | $172 | $13 |
| Triamcinolone Acetonide | 13 | $139 | $11 |
| Glipizide | 14 | $136 | $10 |
| Hydrocortisone | 11 | $71 | $6 |
| Hydroxyzine | 12 | $69 | $6 |
2021: 24 drugs
| Trulicity | 12 | $10,656 | $888 |
| Ezetimibe | 11 | $1,029 | $94 |
| Atorvastatin | 61 | $1,027 | $17 |
| Albuterol Sulfate Hfa | 23 | $1,003 | $44 |
| Levothyroxine | 34 | $787 | $23 |
| Fluticasone Propionate | 38 | $467 | $12 |
| Fosinopril | 15 | $449 | $30 |
| Metformin | 45 | $447 | $10 |
| Losartan | 36 | $422 | $12 |
| Olopatadine | 12 | $352 | $29 |
| Omeprazole | 35 | $317 | $9 |
| Amlodipine Besylate | 37 | $276 | $7 |
| Gabapentin | 12 | $268 | $22 |
| Montelukast | 14 | $266 | $19 |
| Glipizide | 15 | $209 | $14 |
| Alendronate | 23 | $205 | $9 |
| Baclofen | 16 | $159 | $10 |
| Hydrocortisone | 15 | $142 | $9 |
| Lisinopril | 14 | $133 | $9 |
| Tamsulosin | 13 | $124 | $10 |
| Triamcinolone Acetonide | 11 | $94 | $9 |
| Chlorhexidine Gluconate | 12 | $87 | $7 |
| Metoprolol | 12 | $84 | $7 |
| Hydroxyzine | 15 | $78 | $5 |
2020: 33 drugs
| Trulicity | 14 | $10,784 | $770 |
| Flovent Hfa | 21 | $5,996 | $286 |
| Bystolic | 12 | $3,580 | $298 |
| Ventolin Hfa | 22 | $1,250 | $57 |
| Levothyroxine | 45 | $1,222 | $27 |
| Fluticasone Propionate | 80 | $1,086 | $14 |
| Albuterol Sulfate Hfa | 23 | $1,032 | $45 |
| Atorvastatin | 80 | $936 | $12 |
| Amlodipine Besylate | 74 | $597 | $8 |
| Pravastatin | 23 | $428 | $19 |
| Losartan | 43 | $415 | $10 |
| Metformin | 50 | $375 | $8 |
| Azelastine | 11 | $363 | $33 |
| Diclofenac | 12 | $351 | $29 |
| Famotidine | 21 | $338 | $16 |
| Pantoprazole | 22 | $287 | $13 |
| Glipizide | 17 | $261 | $15 |
| Omeprazole | 33 | $247 | $7 |
| Gabapentin | 20 | $240 | $12 |
| Fosinopril | 16 | $232 | $14 |
| Lactulose | 26 | $201 | $8 |
| Furosemide | 29 | $185 | $6 |
| Finasteride | 14 | $175 | $12 |
| Baclofen | 14 | $164 | $12 |
| Simvastatin | 25 | $155 | $6 |
| Carvedilol | 20 | $154 | $8 |
| Lisinopril | 23 | $141 | $6 |
| Alendronate | 14 | $139 | $10 |
| Atenolol | 13 | $125 | $10 |
| Montelukast | 19 | $111 | $6 |
| Metoprolol | 12 | $100 | $8 |
| Hydrocortisone | 13 | $90 | $7 |
| Hydrochlorothiazide | 14 | $66 | $5 |
2019: 41 drugs
| Flovent Hfa | 31 | $7,435 | $240 |
| Ventolin Hfa | 50 | $2,776 | $56 |
| Levothyroxine | 51 | $1,282 | $25 |
| Atorvastatin | 74 | $1,257 | $17 |
| Amlodipine Besylate | 124 | $931 | $8 |
| Fluticasone Propionate | 87 | $875 | $10 |
| Gabapentin | 53 | $750 | $14 |
| Proair Hfa | 11 | $676 | $61 |
| Albuterol Sulfate Hfa | 13 | $541 | $42 |
| Losartan | 56 | $459 | $8 |
| Furosemide | 52 | $452 | $9 |
| Ketoconazole | 11 | $424 | $39 |
| Metformin | 57 | $421 | $7 |
| Famotidine | 38 | $353 | $9 |
| Fosinopril | 14 | $321 | $23 |
| Omeprazole | 33 | $285 | $9 |
| Montelukast | 19 | $266 | $14 |
| Glipizide | 25 | $248 | $10 |
| Simvastatin | 35 | $229 | $7 |
| Metoprolol | 11 | $217 | $20 |
| Lisinopril | 40 | $211 | $5 |
| Atenolol | 20 | $204 | $10 |
| Pravastatin | 18 | $199 | $11 |
| Tamsulosin | 20 | $198 | $10 |
| Baclofen | 29 | $196 | $7 |
| Benazepril | 18 | $192 | $11 |
| Alendronate | 24 | $185 | $8 |
| Carvedilol | 16 | $174 | $11 |
| Pantoprazole | 16 | $165 | $10 |
| Pioglitazone | 11 | $159 | $14 |
| Metoprolol | 22 | $123 | $6 |
| Hydrocortisone | 16 | $117 | $7 |
| Azithromycin | 18 | $114 | $6 |
| Hydrochlorothiazide | 15 | $102 | $7 |
| Triamcinolone Acetonide | 12 | $89 | $7 |
| Sertraline | 11 | $84 | $8 |
| Naproxen | 20 | $79 | $4 |
| Hydrocodone-Acetaminophen | 11 | $79 | $7 |
| Ibuprofen | 17 | $59 | $3 |
| Trazodone | 13 | $55 | $4 |
| Prednisone | 15 | $36 | $2 |
2018: 30 drugs
| Flovent Hfa | 21 | $4,398 | $209 |
| Ventolin Hfa | 32 | $1,711 | $53 |
| Proair Hfa | 17 | $1,108 | $65 |
| Atorvastatin | 53 | $868 | $16 |
| Fluticasone Propionate | 84 | $839 | $10 |
| Levothyroxine | 36 | $682 | $19 |
| Gabapentin | 36 | $469 | $13 |
| Amlodipine Besylate | 75 | $398 | $5 |
| Tamsulosin | 11 | $374 | $34 |
| Baclofen | 33 | $306 | $9 |
| Metformin | 35 | $296 | $8 |
| Triamcinolone Acetonide | 22 | $267 | $12 |
| Losartan | 24 | $240 | $10 |
| Omeprazole | 31 | $225 | $7 |
| Glipizide | 21 | $221 | $11 |
| Lisinopril | 35 | $209 | $6 |
| Atenolol | 20 | $206 | $10 |
| Pantoprazole | 17 | $193 | $11 |
| Simvastatin | 31 | $185 | $6 |
| Fosinopril | 11 | $177 | $16 |
| Famotidine | 21 | $166 | $8 |
| Furosemide | 21 | $166 | $8 |
| Alendronate | 26 | $137 | $5 |
| Hydrochlorothiazide | 12 | $129 | $11 |
| Meclizine | 12 | $123 | $10 |
| Ibuprofen | 27 | $113 | $4 |
| Azithromycin | 14 | $75 | $5 |
| Hydrocortisone | 12 | $75 | $6 |
| Naproxen | 11 | $74 | $7 |
| Trazodone | 14 | $69 | $5 |
2017: 18 drugs
| Flovent Hfa | 13 | $3,327 | $256 |
| Ventolin Hfa | 24 | $1,220 | $51 |
| Fluticasone Propionate | 45 | $492 | $11 |
| Atorvastatin | 39 | $416 | $11 |
| Levothyroxine | 18 | $287 | $16 |
| Amlodipine Besylate | 36 | $184 | $5 |
| Atenolol | 12 | $173 | $14 |
| Gabapentin | 24 | $171 | $7 |
| Omeprazole | 19 | $113 | $6 |
| Losartan | 15 | $106 | $7 |
| Metformin | 19 | $102 | $5 |
| Pantoprazole | 11 | $97 | $9 |
| Baclofen | 13 | $86 | $7 |
| Cephalexin | 13 | $78 | $6 |
| Ibuprofen | 17 | $65 | $4 |
| Azithromycin | 11 | $63 | $6 |
| Alendronate | 12 | $50 | $4 |
| Tramadol | 15 | $37 | $2 |
Professional record
- NPI
- 1710106737
- Licence
- CA NP13945
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 19 W 39th Ave, San Mateo, CA, 94403
- NPI first listed
- 2007-04-25
- NPI last updated
- 2014-08-21
This is when the NPI record was last certified, not a medical board exam.